← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mirecule, Inc.
Gaithersburg, MD
$7,599,954
Total funding
5
Grants
Funding over time
peak $2.1M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,599,954 · 5
By mechanism
R44$4,884,273 · 2
U44$2,000,000 · 1
U43$410,681 · 1
N01$305,000 · 1
Investigators at Mirecule, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular Disorders$1,225,173
R44 · FY2025 · NS
A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular Disorders$1,159,302
R44 · FY2024 · NS
Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment$1,000,000
U44 · FY2021 · CA
Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment$1,000,000
U44 · FY2020 · CA
Development of an antibody-oligonucleotide conjugate for treatment of Head and Neck Squamous Cell Carcinoma$896,878
R44 · FY2025 · CA
Development of an antibody-oligonucleotide conjugate for treatment of Head and Neck Squamous Cell Carcinoma$863,708
R44 · FY2024 · CA
A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular Disorders$370,531
R44 · FY2021 · NS
A Novel RNA Therapeutics Platform to Treat Facioscapulohumeral Muscular Dystrophy and other Neuromuscular Disorders$368,681
R44 · FY2022 · NS
Development of a CXCR4 Targeted miR-29b-3p microRNA Mimic to Treat HIV$305,000
N01 · FY2018 · AI
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement Therapy for Multi-drug Resistant Cancer Treatment$299,267
U43 · FY2017 · CA
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement Therapy for Multi-drug Resistant Cancer Treatment$61,463
U43 · FY2019 · CA
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement$49,951
U43 · FY2018 · CA